Latest filing published 14 Feb 2022 for Zentalis Pharmaceuticals, Inc., €27k.
Filing timeline
BuySaleInsider track record
Alexis Pinto: trading record in brief
Alexis Pinto, listed as senior executive, appears in our data through filings on Zentalis Pharmaceuticals, Inc. shares, published by SEC (Form 4). Between 11 February 2021 and 14 February 2022, the trades on record add up to 9 filings.
On the market, this insider has only sold: 6 sales, €2.0M in total. Outside the open market, there are 2 share grants and 1 option exercise. In 2022 alone, the filings show no purchases and 2 sales.
On 14 February 2022 came the latest disclosure, an open-market sale for €27k in Zentalis Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Alexis Pinto
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 614 shares@ US$50.16Common StockSEC:0001725160-22-000034:1
- 77 shares@ US$50.750.0% of flowCommon StockSEC:0001725160-22-000034:2
- 16,405 shares0Common StockSEC:0001725160-22-000034:0
- 1,800 shares@ US$76.10Common StockSEC:0001725160-21-000206:1
- 8,098 shares@ US$77.27Common StockSEC:0001725160-21-000206:2
- 19,802 shares@ US$78.05Common StockSEC:0001725160-21-000206:3
- 300 shares@ US$78.85Common StockSEC:0001725160-21-000206:4
- 30,000 shares@ US$34.40100.0% of flowCommon StockSEC:0001725160-21-000206:0
- 6,250 shares0Common StockSEC:0001725160-21-000040:0
9 of 9 declarations